🔗 Share this article

The Nobel Prize in medical science was granted for revolutionary discoveries that illuminate how the immune system attacks harmful infections while protecting the healthy tissues.

A trio of renowned researchers—Japan's Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this accolade.

The research identified unique "security guards" within the immune system that eliminate rogue immune cells that could attacking the organism.

The discoveries are now paving the way for innovative therapies for immune disorders and cancer.

These winners will share a prize fund worth 11 million Swedish kronor.

Crucial Findings

"Their research has been essential for comprehending how the immune system functions and why we don't all suffer from serious self-attack conditions," commented the chair of the award panel.

This trio's research address a core question: How does the immune system protect us from numerous infections while leaving our healthy cells intact?

Our body's protection system uses immune cells that search for signs of disease, including pathogens and germs it has not met before.

Such cells utilize sensors—called recognition units—that are generated randomly in a vast number of combinations.

This provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the mechanism unavoidably produces immune cells that can attack the host.

Protectors of the Immune System

Researchers previously understood that some of these problematic white blood cells were destroyed in the immune organ—where white blood cells mature.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the body's "peacekeepers"—which travel through the system to disarm any defenders that assault the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

The Nobel panel stated, "The findings have laid the foundation for a novel area of research and spurred the development of new treatments, for example for cancer and immune disorders."

Regarding cancer, regulatory T-cells block the system from attacking the tumor, so research are aimed at reducing their quantity.

In autoimmune diseases, experiments are exploring boosting regulatory T-cells so the organism is not being harmed. A similar method could also be effective in reducing the risks of organ transplant failure.

Innovative Experiments

Professor Sakaguchi, from Osaka University, performed tests on rodents that had their thymus extracted, causing autoimmune disease.

He demonstrated that injecting defense cells from healthy animals could prevent the illness—suggesting there was a mechanism for preventing immune cells from attacking the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in rodents and people that resulted in the discovery of a gene critical for the way regulatory T-cells operate.

"Their groundbreaking research has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally targeting the body's own tissues," commented a leading physiology expert.

"This work is a remarkable example of how basic biological study can have broad consequences for human health."